The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Refining the impact of genetic evidence on clinical success
Open accessAbstract
The cost of drug discovery and development is driven primarily by failure 1 , with only about 10% of clinical programmes eventually receiving approval 2–4 . We previously estimated that human genetic evidence doubles the success rate from clinical development to approval 5 . In this study we leverage the growth in genetic evidence over the past decade to better understand the characteristics that distinguish clinical success and failure. We estimate the probability of success for drug mechanisms with genetic support is 2.6 times greater than those without. This relative success varies among therapy areas and development phases, and improves with increasing confidence in the causal gene, but is largely unaffected by genetic effect size, minor allele frequency or year of discovery. These results indicate we are far from reaching peak genetic insights to aid the discovery of targets for more effective drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UniProt: the universal protein knowledgebase
The UniProt Consortium (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1099 · Cited by 4,436
FinnGen provides genetic insights from a well-phenotyped isolated population
Kurki, M. I., Karjalainen, J., Palta, P., Sipilä, T. P., Kristiansson, K., Donner, K. M., Reeve, M. P., Laivuori, H., Aavikko, M., Kaunisto, M. A., et al. (2023) · Nature · doi:10.1038/s41586-022-05473-8 · Cited by 4,233
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359 · cited 1×
“The cost of drug discovery and development is driven primarily by failure 1 , with only about 10% of clinical programmes eventually receiving approval 2–4 .”
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Visscher, P. M., Brown, M. A., McCarthy, M. I., & Yang, J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.11.029 · Cited by 2,425
Resnik, P. (1999) · Journal of Artificial Intelligence Research · doi:10.1613/jair.514 · Cited by 2,047
The support of human genetic evidence for approved drug indications
Nelson, M. R., Tipney, H., Painter, J. L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P. C., Li, M. J., Wang, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3314 · Cited by 1,666
Self-citationThe NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource
Sollis, E., Mosaku, A., Abid, A., Buniello, A., Cerezo, M., Gil, L., Groza, T., Güneş, O., Hall, P., Hayhurst, J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1010 · Cited by 1,641
Estimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585
Cited by
Family-GWAS reveals effects of environment and mating on genetic associations
Tan, T., Jayashankar, H., Guan, J., Nehzati, S. M., Mir, M., Bennett, M., Agerbo, E., Ahlskog, R., de Andrade Anapaz, V. P., Benonisdottir, S., et al. (2024) · doi:10.1101/2024.10.01.24314703 · Cited by 47
A systematic comparison of computational methods for expression forecasting
Kernfeld, E., Yang, Y., Weinstock, J. S., Battle, A., & Cahan, P. (2023) · doi:10.1101/2023.07.28.551039 · Cited by 15
Suhre, K., Chen, Q., Halama, A., Mendez, K., Dahlin, A., Stephan, N., Thareja, G., Sarwath, H., Guturu, H., Dwaraka, V. B., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02413-w · Cited by 14
Li, J., Shringarpure, S., Wong, E., & Ho, A. (2026) · doi:10.64898/2026.06.29.735386
Osman, W. (2026) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.71404
Metadata
- Authors
- Minikel, E. V., Painter, J. L., Dong, C. C., & Nelson, M. R.
- Venue
- Nature
- Published
- 2024-04-17
- Volume
- 629
- Issue
- 8012
- Pages
- 624-629
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W4394892101
- Cited by
- 337
- References
- 34
- FWCI
- 80.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Refining the impact of genetic evidence on clinical success. https://app.cochat.ai/papers/10.1038/s41586-024-07316-0
- The paper
- Minikel, E. V., Painter, J. L., Dong, C. C., & Nelson, M. R. (2024). Refining the impact of genetic evidence on clinical success. Nature. https://doi.org/10.1038/s41586-024-07316-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.